165 related articles for article (PubMed ID: 9252857)
21. The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study.
Kim HJ; Kim BH; Han YS; Yang I; Kim KJ; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
Am J Gastroenterol; 2001 Jan; 96(1):165-9. PubMed ID: 11197248
[TBL] [Abstract][Full Text] [Related]
22. Hepatotoxicity and cutaneous reactions after antithyroid drug administration.
Otsuka F; Noh JY; Chino T; Shimizu T; Mukasa K; Ito K; Ito K; Taniyama M
Clin Endocrinol (Oxf); 2012 Aug; 77(2):310-5. PubMed ID: 22332800
[TBL] [Abstract][Full Text] [Related]
23. Changes in liver biochemical tests at diagnosis and after propylthiouracil therapy for hyperthyroidism.
Gürlek A; Cobankara V; Bayraktar M
Mater Med Pol; 1996; 28(3):103-6. PubMed ID: 9167420
[TBL] [Abstract][Full Text] [Related]
24. [The clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism].
Lian XL; Bai Y; Dai WX; Jin ZM; Zeng ZP; Guo ZS
Zhonghua Nei Ke Za Zhi; 2004 Jun; 43(6):442-6. PubMed ID: 15312442
[TBL] [Abstract][Full Text] [Related]
25. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
26. Gone (from the Physicians' desk reference) but not forgotten: propylthiouracil-associated hepatic failure: a call for liver test monitoring.
Primeggia J; Lewis JH
J Natl Med Assoc; 2010 Jun; 102(6):531-4. PubMed ID: 20575220
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment with carbimazole of a hyperthyroid pregnancy with hepatic impairment after propylthiouracil administration: a case report.
Kontoleon P; Ilias I; Koutras DA; Kontogiannis D; Papapetrou PD
Clin Exp Obstet Gynecol; 2002; 29(4):304-5. PubMed ID: 12635752
[TBL] [Abstract][Full Text] [Related]
28. Lichenoid drug eruption of nails induced by propylthiouracil.
Saito M; Nakamura K; Kaneko F
J Dermatol; 2007 Oct; 34(10):696-8. PubMed ID: 17908140
[TBL] [Abstract][Full Text] [Related]
29. The propylthiouracil dilemma.
Glinoer D; Cooper DS
Curr Opin Endocrinol Diabetes Obes; 2012 Oct; 19(5):402-7. PubMed ID: 22820213
[TBL] [Abstract][Full Text] [Related]
30. [Two cases of serious hepatic injury caused by antithyroid drugs].
Grzywa M; Orłowska-Florek R; Grzywa-Celińska A
Endokrynol Pol; 2009; 60(5):396-400. PubMed ID: 19885811
[TBL] [Abstract][Full Text] [Related]
31. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
[TBL] [Abstract][Full Text] [Related]
32. Propylthiouracil-Induced Vasculitis With Antineutrophil Cytoplasmic Antibody.
Criado PR; Grizzo Peres Martins AC; Gaviolli CF; Alavi A
Int J Low Extrem Wounds; 2015 Jun; 14(2):187-91. PubMed ID: 25256279
[TBL] [Abstract][Full Text] [Related]
33. The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration.
Bahn RS; Burch HS; Cooper DS; Garber JR; Greenlee CM; Klein IL; Laurberg P; McDougall IR; Rivkees SA; Ross D; Sosa JA; Stan MN
Thyroid; 2009 Jul; 19(7):673-4. PubMed ID: 19583480
[No Abstract] [Full Text] [Related]
34. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leukocytoclastic vasculitis induced by propylthiouracil confirmed by positive patch test: a case report and review of the literature.
Morais P; Baudrier T; Mota A; Cunha AP; Alves M; Neves C; Capela J; Sá-Couto P; Azevedo F
Cutan Ocul Toxicol; 2011 Jun; 30(2):147-53. PubMed ID: 21091384
[TBL] [Abstract][Full Text] [Related]
35. Propylthiouracil-induced bronchiolitis obliterans organizing pneumonia.
Lee J; Choi SH; Choi KJ; Cha SI; Park TI; Kim CH
Intern Med; 2013; 52(23):2657-9. PubMed ID: 24292758
[TBL] [Abstract][Full Text] [Related]
36. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
[TBL] [Abstract][Full Text] [Related]
37. Propylthiouracil-induced hemolytic anemia.
Kuo CS; Lin JS; Lin HD
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Dec; 64(12):735-8. PubMed ID: 11922496
[TBL] [Abstract][Full Text] [Related]
38. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
39. A fatal case of propylthiouracil-induced ANCA-associated vasculitis resulting in rapidly progressive glomerulonephritis, acute hepatic failure, and cerebral angiitis.
Khan TA; Yin Luk FC; Uqdah HT; Arif A; Hussain H; Jayatilleke A; Aggarwal S
Clin Nephrol; 2015 May; 83(5):309-14. PubMed ID: 25208313
[TBL] [Abstract][Full Text] [Related]
40. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]